Klippel-Trenaunay syndrome (KTS) is a rare congenital condition defined by three hallmark features: a port-wine stain (a flat, reddish-purple birthmark), abnormal veins, and overgrowth of bone and soft tissue, almost always affecting one limb.1American Journal of Medical Genetics. Klippel-Trenaunay syndrome The condition appears at birth or in early infancy and varies enormously from person to person, ranging from a barely noticeable birthmark with mild leg-length difference to extensive vascular malformations that involve internal organs. Because KTS sits within a broader family of overgrowth syndromes and because its complications can quietly worsen over time, understanding what drives it and what to watch for matters more than the diagnosis alone might suggest.
The Classic Triad and How It Actually Presents
The textbook description of KTS centers on three features appearing together: a capillary malformation (port-wine stain), venous or lymphatic anomalies, and limb hypertrophy. In practice, not every person with KTS checks all three boxes at the same time. The birthmark is usually the most visible sign, typically covering part or all of the affected limb, and it can thicken or develop small blistering bumps (called blebs) over the years. The venous component ranges from superficial varicose veins that appear unusually early in life to deep structural abnormalities in how the veins formed. Limb overgrowth can involve length, girth, or both, and the affected leg or arm may be noticeably larger than its counterpart from toddlerhood onward.
A documented variant sometimes called “inverse KTS” flips one part of the triad: instead of limb overgrowth, the affected limb is shorter or smaller than expected.2PubMed Central. Klippel-Trenaunay syndrome or not? An exploration of atypical presentations This atypical presentation can delay diagnosis because clinicians may not think of KTS when the limb difference runs in the “wrong” direction. The key clue is usually the port-wine stain paired with vascular anomalies on imaging.
What Causes KTS at the Genetic Level
KTS is not inherited in the way most people think of genetic conditions. It arises from somatic mutations, meaning the genetic change happens randomly after conception in a subset of the body’s cells rather than being passed down from a parent. The gene most consistently implicated is PIK3CA, which encodes part of an enzyme involved in cell growth signaling.3PubMed Central. The Klippel-Trénaunay Syndrome in 2022: Unravelling Its Genetic and Molecular Profile and Its Link to the Limb Overgrowth Syndromes When PIK3CA carries an activating mutation, the affected cells grow and divide more readily than they should, leading to the overgrowth of tissue and the formation of abnormal blood and lymphatic vessels.
Because the same gene is mutated in several other overgrowth conditions, researchers now classify KTS within a broader category called PIK3CA-related overgrowth spectrum, or PROS.4PubMed. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS) This reclassification is more than academic bookkeeping. It means that drugs originally developed for other PROS conditions, or even for cancers driven by the same pathway, can potentially benefit people with KTS. It also means that the old habit of treating KTS as a completely distinct entity from related syndromes is fading in favor of a molecular approach: identify the mutation, then match the therapy to the pathway.
Distinguishing KTS From Look-Alike Conditions
The condition most commonly confused with KTS is Parkes Weber syndrome. Both involve a port-wine stain and limb overgrowth, but the vascular mechanics differ in a way that matters for treatment. KTS is a low-flow condition, meaning the abnormal vessels are veins and lymphatics that move blood slowly. Parkes Weber syndrome, by contrast, features high-flow arteriovenous fistulas where arterial blood shunts directly into veins.5PubMed. Parkes Weber or Klippel-Trenaunay syndrome? Non-invasive diagnosis with MR projection angiography The distinction is critical because treating a high-flow malformation the same way you would treat a low-flow one can lead to serious complications. MRI-based angiography can sort this out noninvasively, but the diagnostic step is sometimes skipped when clinicians assume one diagnosis based on appearance alone.
Venous Abnormalities and Why They Matter
The venous system in KTS is not just “varicose veins that showed up early.” Many people with KTS have structurally abnormal veins that formed differently during embryonic development. One well-known example is the lateral marginal vein of Servelle, an embryonic vein that normally disappears before birth but persists in some KTS patients as a large superficial vein running along the outer side of the leg.6PubMed Central. A rare case of persistent lateral marginal vein of Servelle in Klippel Trenaunay Syndrome: A successful surgical management These persistent embryonic veins are a major source of venous hypertension, meaning blood pools and pressure builds in the leg, contributing to swelling, pain, and skin changes over time.7PubMed. Transcatheter embolization of persistent embryonic veins in venous malformation syndromes
Understanding the anatomy of these abnormal veins is important before any intervention. If the deep venous system is absent or underdeveloped, an embryonic vein like the marginal vein may be the only pathway draining blood from the limb. Removing or closing it without confirming that the deep veins can handle the load would cause the leg to swell dramatically. Duplex ultrasound and MRI are standard tools for mapping the venous anatomy before any treatment decisions are made.
Skin and Lymphatic Complications
The port-wine stain itself is more than a cosmetic concern. A large retrospective review of over 400 KTS patients found that the most common skin complications were related to the capillary malformation: bleb formation, bleeding from the skin surface, thickening of the birthmark (affecting about a quarter of patients), cellulitis (around a fifth), and ulceration (around a fifth).8PubMed. Skin-Related complications of Klippel-Trenaunay Syndrome: a retrospective review of 410 patients Having a lymphatic malformation alongside the venous and capillary components dramatically increased the odds of developing skin complications. Lymphatic malformations cause chronic swelling and fluid leakage, creating a favorable environment for bacterial infections like cellulitis.
Pulsed-dye laser treatment has shown success in treating the port-wine stain, particularly when started early. One case report documented complete clearance of the birthmark in a two-week-old infant after three sessions of pulsed-dye laser, with no recurrence over seven years of follow-up and a halt in the associated soft-tissue overgrowth.9PubMed Central. Successful Treatment of Unilateral Klippel-Trenaunay Syndrome With Pulsed-Dye Laser in a 2-Week Old Infant That level of response is not typical for older patients, whose thicker, more established birthmarks are harder to treat, but it highlights the potential value of early intervention. Laser treatment does not address the deeper vascular or overgrowth components, so it is one piece of a broader management plan rather than a standalone cure.
Blood Clots and the Thromboembolic Threat
One of the most dangerous aspects of KTS is an increased tendency to form blood clots. The abnormal, slow-flowing veins create conditions ripe for deep vein thrombosis, and the risk does not stop there. If a clot breaks loose and travels to the lungs, it causes a pulmonary embolism, which can be fatal. A case report described a patient who experienced a massive pulmonary embolism simply from having her leg raised during preparation for surgery, which mechanically dislodged a pre-existing clot.10PubMed Central. Massive pulmonary embolism in Klippel-Trenaunay syndrome after leg raising: A case report This kind of event underscores why anyone with KTS facing surgery or procedures involving the affected limb needs careful planning around clot prevention.
Some patients require long-term anticoagulation, and even that may not fully eliminate the risk. A case involving a KTS patient on therapeutic-dose anticoagulation who was also receiving sirolimus still developed extensive venous thromboembolism.11PubMed Central. Deep vein thrombosis in the setting of Klippel-Trenaunay syndrome and sirolimus treatment The interaction between KTS-related venous anatomy and clotting risk is not a simple problem solved by a single medication, and it requires ongoing vigilance from the medical team.
When the Condition Extends Beyond the Limb
KTS is usually thought of as a limb condition, but vascular malformations can involve internal organs. Gastrointestinal bleeding is the most recognized visceral complication, with reported rates ranging from roughly 2% to 23% of KTS patients depending on the study and how aggressively bleeding was looked for.12PubMed Central. Klippel–Trenaunay syndrome with multiorgan vascular involvement and gastrointestinal bleeding: A case report and literature review The bleeding comes from vascular malformations in the lining of the gut, particularly cavernous angiomas in the colon and rectum. In severe cases, patients present with life-threatening hemorrhage and anemia requiring blood transfusions.13PubMed. Bleeding from cavernous angiomatosis of the rectum in Klippel-Trenaunay syndrome: report of three cases and literature review
Splenic hemangiomas, bladder involvement, and other organ-level vascular malformations have also been documented, though they are less common.14PubMed Central. Klippel-Trenaunay syndrome with gastrointestinal bleeding, splenic hemangiomas and left inferior vena cava For patients with KTS, unexplained anemia, rectal bleeding, or blood in the stool warrants investigation for GI involvement even if the limb symptoms seem stable.
Limb Length Discrepancy and Orthopedic Management
Overgrowth of the affected limb creates a leg-length difference that, beyond a certain point, throws off gait and stresses the spine, hips, and knees. The decision about whether to intervene surgically hinges on how much discrepancy is projected at skeletal maturity. A leg-length difference expected to exceed about 2 centimeters is generally considered the threshold for considering epiphysiodesis, a procedure that slows growth in the longer leg by surgically arresting the growth plate near the knee.15Mayo Clinic Proceedings. Klippel-Trénaunay Syndrome: Spectrum and Management Timing matters: the procedure works only in growing children, so orthopedic teams track growth trajectories carefully with serial imaging to intervene before the window closes.
For smaller discrepancies, a shoe lift often suffices. For larger ones where the growth plate has already closed, more involved surgical options exist, but they come with higher complication risks in a patient population already prone to bleeding and clotting problems. The overall approach is to manage the discrepancy conservatively when possible and reserve surgery for cases where the functional impairment justifies the risk.
Treatment With Sirolimus and Targeted Therapies
Because KTS results from overactivation of a specific cell-growth pathway, drugs that dampen that pathway have emerged as treatment options over the past decade. Sirolimus (also known as rapamycin) was the first to gain traction. In a prospective study of patients with slow-flow vascular malformations, a KTS patient treated with sirolimus for six months showed measurable physical improvement: reduced thigh volume, better skin color, disappearance of bleeding and oozing, resolution of infections, and improved mobility.16PubMed Central. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study Sirolimus is not curative, and the malformations tend to progress again if the drug is stopped, but it can substantially improve quality of life.
A newer and more targeted option is alpelisib, a drug that directly inhibits the PI3K-alpha enzyme encoded by PIK3CA. One case described a 42-year-old woman with KTS who had been on sirolimus and long-term anticoagulation for nearly a decade with only partial control of her symptoms and chronic opioid dependence for pain. After switching to alpelisib, her right thigh circumference dropped from 53.5 cm to 48 cm, her shoe size decreased from a women’s 8 to 6.5, and she was able to stop taking opioids entirely and start a daily walking program within four months.17PubMed Central. Clinical Response to PI3K-α Inhibition in a Cohort of Children and Adults With PIK3CA-Related Overgrowth Spectrum Disorders The trade-off was significant hyperglycemia that required dose adjustment and dietary changes. Alpelisib is still relatively new in this setting, and access can be difficult, but it represents a meaningful step toward treating the molecular root of the condition rather than just managing symptoms.
Procedures for Venous Insufficiency
When abnormal veins cause persistent pain, swelling, and skin damage, closing them off can provide relief. Endovenous radiofrequency ablation, which uses heat delivered through a catheter to seal incompetent veins, has been used successfully in KTS patients. In reported cases, radiofrequency ablation combined with ultrasound-guided foam sclerotherapy (injecting a foaming agent to collapse residual veins) achieved complete occlusion of the targeted vessels, with marked improvement in pain, cramping, swelling, and the bulging appearance of surface veins.18PubMed Central. Endovenous Radiofrequency Thermal Ablation and Ultrasound-Guided Foam Sclerotherapy in Treatment of Klippel-Trenaunay Syndrome19Journal of Vascular Surgery. Endovascular radiofrequency ablation: A novel treatment of venous insufficiency in Klippel-Trenaunay patients These are minimally invasive compared to traditional vein stripping surgery and can be done in stages under local anesthesia.20PubMed. Endovenous radiofrequency ablation and combined foam sclerotherapy treatment of multiple refluxing perforator veins in a Klippel-Trenaunay syndrome patient
The critical prerequisite, as mentioned earlier, is confirming that the deep venous system is intact and functional before closing superficial or embryonic veins. Without that step, sealing off the wrong vein could make the limb dramatically worse. Pre-procedure imaging with duplex ultrasound and often MRI is standard practice for this reason.
Pain, Mental Health, and Living With KTS
KTS is not just a physical condition. Pain is reported by roughly two-thirds of patients, most strongly linked to venous malformations in the lower legs and feet.21Journal of the American Academy of Dermatology. Pain, psychiatric comorbidities, and psychosocial stressors associated with Klippel-Trenaunay syndrome The pain is often chronic, worsened by standing or activity, and can be difficult to manage because it stems from structural vascular problems rather than something a standard painkiller targets easily.
About a quarter of KTS patients in one large study had a diagnosed psychiatric condition, with depression being the most common, followed by anxiety.22Journal of the American Academy of Dermatology. Pain, psychiatric comorbidities, and psychosocial stressors associated with Klippel-Trenaunay syndrome Pain itself was strongly associated with having a psychiatric diagnosis, as were complications like thrombosis and GI bleeding. Quality-of-life studies have found that KTS patients score significantly lower than the general population on measures of physical functioning and bodily pain, and their symptom burden on skin-specific questionnaires tends to fall in the severe range.23PubMed. Baseline Quality of Life in patients with Klippel-Trenaunay syndrome The emotional and social toll of living with a visible, progressive condition that few people have heard of adds another layer of difficulty that does not always get addressed in a vascular clinic.
Prenatal Detection
KTS can sometimes be suspected before birth. Limb asymmetry and subcutaneous or internal hemangiomas visible on prenatal ultrasound may prompt further investigation. In utero MRI has been used to confirm the diagnosis prenatally, showing findings that matched ultrasound and allowed families and medical teams to prepare for the delivery and early management of a child with KTS.24PubMed. Klippel-Trenaunay-Weber (KTW) syndrome: the use of in utero magnetic resonance imaging (MRI) in a prospective diagnosis Prenatal detection does not change the fundamental trajectory of the condition, but it can shape delivery planning, alert neonatologists to potential bleeding or clotting risks, and give families time to connect with specialists before the baby arrives.
The Adult Care Gap
One of the most frustrating realities for people living with KTS is what happens when they age out of pediatric care. A survey of adults with vascular anomalies found that among those still seeing a pediatric provider, virtually none had a plan for transitioning to an adult specialist. After being discharged from pediatric care, the vast majority had no transition plan in place. About a third had given up searching for an adult physician willing to manage their condition, and nearly half had no consistent care provider for their vascular anomaly at all.25Journal of Vascular Anomalies. Survey of Adult Patients With Vascular Anomalies Reveals Acute Need of Adult Hematologists-Oncologists to Enter the Field
This gap exists because KTS and related conditions were historically managed by pediatric specialists, and the field of adult vascular anomaly medicine is still developing. The consequences are real: without ongoing monitoring, complications like worsening venous insufficiency, clot formation, and GI bleeding can go undetected until they become emergencies. Multidisciplinary vascular anomaly centers that serve both children and adults do exist at some academic medical centers, but they are geographically sparse. For many adults with KTS, coordinating their own care across vascular surgery, hematology, dermatology, orthopedics, and sometimes gastroenterology becomes a part-time job in itself.